- View all
- News
- 3billion
My Odyssey #10 - Diagnosis story of a girl diagnosed with TFE3-related neurodevelopmental disorder
Olivia’s story diagnosed with TFE3-related neurodevelopmental disorder
- 3billion
- 2021.06.02
Immediate Diagnosis Through Collaboration with Dr. Alisdair McNeill
3billion Inc reflects Dr. Alisdair McNeill’s latest finding on genetic variants to end diagnostic odyssey
- 3billion
- 2021.05.12
3billion announces Dr. Hane Lee of UCLA as Chief Clinical Geneticist
3billion announced this May 10th Dr. Hane Lee of UCLA to direct their genetic laboratory.
- BioSpectator
- 2021.05.10
Rare Disease Series #22 Vertebral, cardiac, tracheoesophageal, renal, and limb defects (VCTERL)
Vertebral, cardiac, tracheoesophageal, renal, and limb defects (VCTERL) is a rare genetic disorder characterized by congenital heart disease, abnormal vertebral morphology, renal abnormalities, and limb abnormalities.
- 3billion
- 2021.05.06
Korean Rare Disease Diagnostics Firm 3billion Looks to 2022 IPO, Expansion Into Drug Discovery
3billion is on track to go public by early 2022; with further ambitions to expand into novel drug discovery.
- Genomeweb
- 2021.04.19
My Odyssey #9 - Irene's story diagnosed with Vertebral, cardiac, tracheoesophageal, renal, and limb defects (VCTERL)
Diagnosis story of a girl diagnosed with Vertebral, cardiac, tracheoesophageal, renal, and limb defects (VCTERL)
- 3billion
- 2021.04.15
Rare Disease Series #21 IPEX
Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked (IPEX) is a rare genetic disorder characterized by multiple autoimmune symptoms in organs.
- 3billion
- 2021.03.29
Rare Disease Screening Firm 3Billion Closes $13M Series C Financing
3billion has closed its Series C funding round raising $13 million, a total of $30 million since its seed round in 2017.
- Genomeweb
- 2021.03.26